Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102


A Novel Lactococcal Vaccine Expressing a Peptide from the M2 Antigen of H5N2 Highly Pathogenic Avian Influenza A Virus Prolongs Survival of Vaccinated Chickens.

Reese KA, Lupfer C, Johnson RC, Mitev GM, Mullen VM, Geller BL, Pastey M.

Vet Med Int. 2013;2013:316926. doi: 10.1155/2013/316926. Epub 2013 May 22.


Immunogenicity and protective efficacy of the norovirus P particle-M2e chimeric vaccine in chickens.

Elaish M, Kang KI, Xia M, Ali A, Shany SA, Wang L, Jiang X, Lee CW.

Vaccine. 2015 Sep 11;33(38):4901-9. doi: 10.1016/j.vaccine.2015.07.049. Epub 2015 Jul 29.


Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus.

Kapczynski DR, Esaki M, Dorsey KM, Jiang H, Jackwood M, Moraes M, Gardin Y.

Vaccine. 2015 Feb 25;33(9):1197-205. doi: 10.1016/j.vaccine.2014.12.028. Epub 2015 Jan 20.


Recombinant M2e protein-based ELISA: a novel and inexpensive approach for differentiating avian influenza infected chickens from vaccinated ones.

Hemmatzadeh F, Sumarningsih S, Tarigan S, Indriani R, Dharmayanti NL, Ebrahimie E, Igniatovic J.

PLoS One. 2013;8(2):e56801. doi: 10.1371/journal.pone.0056801. Epub 2013 Feb 21.


Prokaryote-expressed M2e protein improves H9N2 influenza vaccine efficacy and protection against lethal influenza A virus in mice.

Kim EH, Lee JH, Pascua PN, Song MS, Baek YH, Kwon HI, Park SJ, Lim GJ, Decano A, Chowdhury MY, Seo SK, Song MK, Kim CJ, Choi YK.

Virol J. 2013 Apr 3;10:104. doi: 10.1186/1743-422X-10-104.


Vaccination of chickens with recombinant Salmonella expressing M2e and CD154 epitopes increases protection and decreases viral shedding after low pathogenic avian influenza challenge.

Layton SL, Kapczynski DR, Higgins S, Higgins J, Wolfenden AD, Liljebjelke KA, Bottje WG, Swayne D, Berghman LR, Kwon YM, Hargis BM, Cole K.

Poult Sci. 2009 Nov;88(11):2244-52. doi: 10.3382/ps.2009-00251. Review.


A Novel Vaccine Using Nanoparticle Platform to Present Immunogenic M2e against Avian Influenza Infection.

Babapoor S, Neef T, Mittelholzer C, Girshick T, Garmendia A, Shang H, Khan MI, Burkhard P.

Influenza Res Treat. 2011;2011:126794. doi: 10.1155/2011/126794. Epub 2012 Jan 12.


Development of an M2e-specific enzyme-linked immunosorbent assay for differentiating infected from vaccinated animals.

Lambrecht B, Steensels M, Van Borm S, Meulemans G, van den Berg T.

Avian Dis. 2007 Mar;51(1 Suppl):221-6.


An H5N1-based matrix protein 2 ectodomain tetrameric peptide vaccine provides cross-protection against lethal infection with H7N9 influenza virus.

Leung HC, Chan CC, Poon VK, Zhao HJ, Cheung CY, Ng F, Huang JD, Zheng BJ.

Emerg Microbes Infect. 2015 Apr;4(4):e22. doi: 10.1038/emi.2015.22. Epub 2015 Apr 8.


[Construction and immunogenicity of recombinant bacteriophage T7 vaccine expressing M2e peptides of avian influenza virus].

Xu H, Wang YW, Tang YH, Zheng QS, Hou JB.

Bing Du Xue Bao. 2013 Jun;29(4):376-81. Chinese.


Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.

Sarfati-Mizrahi D, Lozano-Dubernard B, Soto-Priante E, Castro-Peralta F, Flores-Castro R, Loza-Rubio E, Gay-Gutiérrez M.

Avian Dis. 2010 Mar;54(1 Suppl):239-41.


Vaccination with recombinant 4 × M2e.HSP70c fusion protein as a universal vaccine candidate enhances both humoral and cell-mediated immune responses and decreases viral shedding against experimental challenge of H9N2 influenza in chickens.

Dabaghian M, Latify AM, Tebianian M, Nili H, Ranjbar AR, Mirjalili A, Mohammadi M, Banihashemi R, Ebrahimi SM.

Vet Microbiol. 2014 Nov 7;174(1-2):116-26. doi: 10.1016/j.vetmic.2014.09.009. Epub 2014 Sep 23.


Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e.

Park KS, Seo YB, Lee JY, Im SJ, Seo SH, Song MS, Choi YK, Sung YC.

Vaccine. 2011 Jul 26;29(33):5481-7. doi: 10.1016/j.vaccine.2011.05.062. Epub 2011 Jun 12.


Efficacy of a replikin peptide vaccine against low-pathogenicity avian influenza H5 virus.

Jackwood MW, Bogoch S, Bogoch ES, Hilt D, Williams SM.

Avian Dis. 2009 Dec;53(4):613-7.


Distribution of avian influenza H5N1 viral RNA in tissues of AI-vaccinated and unvaccinated contact chickens after experimental infection.

Hassan MK, Kilany WH, Abdelwhab EM, Arafa AS, Selim A, Samy A, Samir M, Le Brun Y, Jobre Y, Aly MM.

Arch Virol. 2012 May;157(5):951-9. doi: 10.1007/s00705-012-1242-x. Epub 2012 Feb 15.


Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry.

Worrall EE, Sudarisman, Priadi A.

Vaccine. 2009 Jun 24;27(31):4161-8. doi: 10.1016/j.vaccine.2009.04.058. Epub 2009 May 9.


Multimeric recombinant M2e protein-based ELISA: a significant improvement in differentiating avian influenza infected chickens from vaccinated ones.

Hadifar F, Ignjatovic J, Tarigan S, Indriani R, Ebrahimie E, Hasan NH, McWhorter A, Putland S, Ownagh A, Hemmatzadeh F.

PLoS One. 2014 Oct 16;9(10):e108420. doi: 10.1371/journal.pone.0108420. eCollection 2014.


An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.

Zhao G, Sun S, Du L, Xiao W, Ru Z, Kou Z, Guo Y, Yu H, Jiang S, Lone Y, Zheng BJ, Zhou Y.

Virol J. 2010 Jul 12;7:151. doi: 10.1186/1743-422X-7-151.


Supplemental Content

Support Center